{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:33:50Z","timestamp":1790044430599,"version":"4.0.1"},"reference-count":59,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>(1) Background: The treatment of peripheral arterial disease (PAD) is focused on improving perfusion and oxygenation in the affected limb. Standard revascularization methods include bypass surgery, endovascular interventional procedures, or hybrid revascularization. Cell-based therapy can be an alternative strategy for patients with no-option critical limb ischemia who are not eligible for endovascular or surgical procedures. (2) Aims: The aim of this narrative review was to provide an up-to-date critical overview of the knowledge and evidence-based medicine data on the position of cell therapy in the treatment of PAD. The current evidence on the cell-based therapy is summarized and future perspectives outlined, emphasizing the potential of exosomal cell-free approaches in patients with critical limb ischemia. (3) Methods: Cochrane and PubMed databases were searched for keywords \u201ccritical limb ischemia and cell therapy\u201d. In total, 589 papers were identified, 11 of which were reviews and 11 were meta-analyses. These were used as the primary source of information, using cross-referencing for identification of additional papers. (4) Results: Meta-analyses focusing on cell therapy in PAD treatment confirm significantly greater odds of limb salvage in the first year after the cell therapy administration. Reported odds ratio estimates of preventing amputation being mostly in the region 1.6\u20133, although with a prolonged observation period, it seems that the odds ratio can grow even further. The odds of wound healing were at least two times higher when compared with the standard conservative therapy. Secondary endpoints of the available meta-analyses are also included in this review. Improvement of perfusion and oxygenation parameters in the affected limb, pain regression, and claudication interval prolongation are discussed. (5) Conclusions: The available evidence-based medicine data show that this technique is safe, associated with minimum complications or adverse events, and effective.<\/jats:p>","DOI":"10.3390\/ijms21238999","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T22:00:33Z","timestamp":1606428033000},"page":"8999","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia"],"prefix":"10.3390","volume":"21","author":[{"given":"Frantisek","family":"Jaluvka","sequence":"first","affiliation":[{"name":"Department of Surgery, University Hospital Ostrava, 708 52 Ostrava, Czech Republic"},{"name":"Department of Surgical Studies, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6353-6257","authenticated-orcid":false,"given":"Peter","family":"Ihnat","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Ostrava, 708 52 Ostrava, Czech Republic"},{"name":"Department of Surgical Studies, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-2336","authenticated-orcid":false,"given":"Juraj","family":"Madaric","sequence":"additional","affiliation":[{"name":"Clinic of Angiology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Vrtkova","sequence":"additional","affiliation":[{"name":"Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB\u2014Technical University of Ostrava, 708 00 Ostrava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Janosek","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2410-2314","authenticated-orcid":false,"given":"Vaclav","family":"Prochazka","sequence":"additional","affiliation":[{"name":"Radiodiagnostic Institute, University Hospital Ostrava, 708 52 Ostrava, Czech Republic"},{"name":"Institute of Imaging Methods, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"ESVM Guideline on peripheral arterial disease","volume":"48","author":"Frank","year":"2019","journal-title":"Vasa"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: The European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_3","unstructured":"Management of Peripheral Arterial Disease (PAD), and TransAtlantic Inter-Society Consensus (TASC) (2000). Section D: Chronic critical limb ischaemia. Eur. J. Vasc. Endovasc. Surg., 19, 144\u2013243."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/iwj.12334","article-title":"Effectiveness of prostaglandin E1 in patients with mixed arterial and venous ulcers of the lower limbs","volume":"13","author":"Massara","year":"2016","journal-title":"Int. Wound J."},{"key":"ref_5","first-page":"731","article-title":"Iloprost infusion in diabetic patients with peripheral arterial occlusive disease and foot ulcers","volume":"6","author":"Mirenda","year":"2005","journal-title":"Chir. Ital. Milano Roma"},{"key":"ref_6","first-page":"177","article-title":"Is revascularization and limb salvage always the treatment for critical limb ischemia?","volume":"45","author":"Nehler","year":"2004","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s100169900083","article-title":"Femoropopliteal bypass: In situ or reversed vein grafts? Ten-year results of a randomized prospective study","volume":"11","author":"Watelet","year":"1997","journal-title":"Ann. Vasc. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J. Vasc. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.ejvs.2009.12.001","article-title":"Stem cell therapy in PAD","volume":"39","author":"Sprengers","year":"2010","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","article-title":"Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature","volume":"209","author":"Fadini","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial","volume":"360","author":"Matsubara","year":"2002","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s40618-019-01053-2","article-title":"Expression of miR-217 and HIF-1alpha\/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats","volume":"42","author":"Lin","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.expneurol.2008.02.027","article-title":"Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat","volume":"211","author":"Andrews","year":"2008","journal-title":"Exp. Neurol."},{"key":"ref_15","first-page":"4296","article-title":"Autologous bone marrow stem cell transplantation in critical limb ischemia: A meta-analysis of randomized controlled trials","volume":"125","author":"Liu","year":"2012","journal-title":"Chin. Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous Bone Marrow-Derived Cell Therapy in Patients With Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Clinical Trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3727\/096368912X636777","article-title":"Safety and efficacy of autologous cell therapy in critical limb ischemia: A systematic review","volume":"22","author":"Benoit","year":"2013","journal-title":"Cell Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.5551\/jat.23374","article-title":"Efficacy of autologous bone marrow mononuclear cell therapy in patients with peripheral arterial disease","volume":"21","author":"Wang","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, Y., Xu, Y., Fang, F., Zhang, J., Guo, L., and Weng, Z. (2015). Therapeutic Efficacy of Stem Cell-based Therapy in Peripheral Arterial Disease: A Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125032"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0003319715595172","article-title":"Cell Therapy for Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials","volume":"67","author":"Liew","year":"2016","journal-title":"Angiology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jcyt.2016.02.009","article-title":"Safety and efficacy of cell-based therapy on critical limb ischemia: A meta-analysis","volume":"18","author":"Ai","year":"2016","journal-title":"Cytotherapy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","article-title":"Autologous Cell Therapy for Peripheral Arterial Disease. Systematic Review and Meta-Analysis of Randomized, Nonrandomized and Noncintrolled Studies","volume":"120","author":"Rigato","year":"2017","journal-title":"Circ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1358863X17752556","article-title":"Therapeutic efficacy of CD34+ cell-involved mononuclera cell therapy for no-option critical limb ischemia: A meta-analysis of randomized controlled clinical trials","volume":"23","author":"Pan","year":"2018","journal-title":"Vasc. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Xie, B., Luo, H., Zhang, Y., Wang, Q., Zhou, C., and Xu, D. (2018). Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled trials. Stem Cells Int., 7528464.","DOI":"10.1155\/2018\/7528464"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mvr.2010.01.012","article-title":"Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation","volume":"79","author":"Tongers","year":"2010","journal-title":"Microvasc. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tcm.2004.10.001","article-title":"Endothelial progenitor cells functional characterization","volume":"14","author":"Urbich","year":"2004","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.ATV.0000073832.49290.B5","article-title":"Endothelial progenitor cells: Mobilization, differentiation, and homing","volume":"23","author":"Hristov","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cheng, M., Guan, X., Li, H., Cui, X., Zhang, X., Li, X., Jing, X., Wu, H., and Avsar, E. (2013). Shear stress regulates late EPC differentiation via mechanosensitive molecule-mediated cytoskeletal rearrangement. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067675"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1253\/circj.68.1189","article-title":"Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells","volume":"68","author":"Saigawa","year":"2004","journal-title":"Circ. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3727\/096368912X636948","article-title":"No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia","volume":"21","author":"Klepanec","year":"2012","journal-title":"Cell Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348","article-title":"Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: A randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"4","author":"Walter","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.106.644518","article-title":"CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells","volume":"114","author":"Kawamoto","year":"2006","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I\/IIa double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V95.3.952.003k27_952_958","article-title":"Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors","volume":"95","author":"Peichev","year":"2000","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(03)12110-1","article-title":"Autologous bone-marrow stem-cell transplantation for myocardial regeneration","volume":"361","author":"Stamm","year":"2003","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/CIRCULATIONAHA.104.522292","article-title":"Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety","volume":"112","author":"Bartunek","year":"2005","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/86498","article-title":"Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function","volume":"7","author":"Kocher","year":"2001","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1387\/ijdb.103167dr","article-title":"The role of pericytes in angiogenesis","volume":"55","author":"Ribatti","year":"2011","journal-title":"Int. J. Dev. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3727\/096368910X509068","article-title":"Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: Therapeutic implications for critical limb ischemia","volume":"19","author":"Cobellis","year":"2010","journal-title":"Cell Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Altaner, C., Altanerova, V., Cihova, M., Hunakova, L., Kaiserova, K., Klepanec, A., Vulev, I., and Madaric, J. (2013). Characterization of mesenchymal stem cells of \u201cno-options\u201d patients with critical limb ischemia treated by autologous bone marrow mononuclear cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073722"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1742-1241.2011.02886.x","article-title":"Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients","volume":"66","author":"Kirana","year":"2012","journal-title":"Int. J. Clin. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"ref_46","first-page":"173","article-title":"Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot","volume":"55","author":"Prochazka","year":"2009","journal-title":"Vnitr. Lek."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3727\/096368910X514170","article-title":"Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer","volume":"19","author":"Prochazka","year":"2010","journal-title":"Cell Transplant."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00270-012-0415-z","article-title":"Intra-arterial autologous bone marrow cell transplantation in a patient with upper-extremity critical limb ischemia","volume":"36","author":"Madaric","year":"2013","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bbrc.2009.12.057","article-title":"Bone marrow-derived cells are differentially involved in pathological and physiological retinal angiogenesis in mice","volume":"391","author":"Zou","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mvr.2010.02.011","article-title":"EPCs and pathological angiogenesis: When good cells go bad","volume":"79","author":"Neu","year":"2010","journal-title":"Microvasc. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbcan.2009.05.001","article-title":"Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression","volume":"1796","author":"Gao","year":"2009","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/ijc.24605","article-title":"Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors","volume":"125","author":"Wickersheim","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3727\/096368915X689767","article-title":"Therapeutic Potential of Adipose-Derived Therapeutic Factor Concentrate for Treating Critical Limb Ischemia","volume":"25","author":"Prochazka","year":"2016","journal-title":"Cell Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","article-title":"Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms","volume":"94","author":"Kinnaird","year":"2004","journal-title":"Circ. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/emm.2013.94","article-title":"Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine","volume":"45","author":"Murphy","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"ref_59","first-page":"511","article-title":"The Role of miR-126 in Critical Limb Ischemia Treatment Using Adipose-Derived Stem Cell Therapeutic Factor Concentrate and Extracellular Matrix Microparticles","volume":"24","author":"Prochazka","year":"2018","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8999\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:38:00Z","timestamp":1760179080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":59,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21238999"],"URL":"https:\/\/doi.org\/10.3390\/ijms21238999","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202011.0193.v1","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]}}}